Global alternative asset manager Apollo Global Management is in talks to acquire Johnson & Johnson's orthopedics unit in a deal that could value it at close to $20 billion, Bloomberg News reported on Friday, citing sources.
An agreement could be reached within several weeks, the report said, adding that the drugmaker could also decide to spin off the unit - known as DePuy Synthes - which has attracted interest from several private equity firms, as a publicly traded company.